Upgrade to SI Premium - Free Trial

Medtronic, Inc. (MDT) PT Lowered to $145 at Needham & Company

November 23, 2021 1:27 PM
Needham & Company analyst Michael Matson lowered the price target on Medtronic, Inc. (NYSE: MDT) to $145.00 (from $152.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles